Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.00026 | 1 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |